KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Finished Goods (2018 - 2025)

Historic Finished Goods for Globus Medical (GMED) over the last 8 years, with Q3 2025 value amounting to $555.7 million.

  • Globus Medical's Finished Goods fell 45.78% to $555.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $555.7 million, marking a year-over-year decrease of 45.78%. This contributed to the annual value of $491.5 million for FY2024, which is 3053.03% down from last year.
  • Per Globus Medical's latest filing, its Finished Goods stood at $555.7 million for Q3 2025, which was down 45.78% from $558.4 million recorded in Q2 2025.
  • Globus Medical's Finished Goods' 5-year high stood at $769.7 million during Q3 2023, with a 5-year trough of $172.1 million in Q3 2021.
  • Moreover, its 5-year median value for Finished Goods was $237.4 million (2023), whereas its average is $390.0 million.
  • As far as peak fluctuations go, Globus Medical's Finished Goods skyrocketed by 27311.71% in 2023, and later plummeted by 3053.03% in 2024.
  • Globus Medical's Finished Goods (Quarter) stood at $177.8 million in 2021, then increased by 23.72% to $220.0 million in 2022, then soared by 221.64% to $707.5 million in 2023, then plummeted by 30.53% to $491.5 million in 2024, then rose by 13.08% to $555.7 million in 2025.
  • Its Finished Goods was $555.7 million in Q3 2025, compared to $558.4 million in Q2 2025 and $497.0 million in Q1 2025.